文献速递血液透析通路

早期肝素诱导性血小板减少症时保留肝素结合人工血管用于血液透析

Preservation of Heparin-Bonded Prosthetic Graft for Hemodialysis in the Setting of Early Heparin-Induced Thrombocytopenia.
PubMed 文献 · Ann Vasc Surg · 2020-01-02

本文报告一例近期置入肝素结合ePTFE动静脉人工血管后发生肝素诱导性血小板减少症(HIT)的罕见病例,通过成功治疗使透析通路得以保留,避免了人工血管切除。

要点

  • 肝素结合ePTFE人工血管用于透析通路日益增多以改善通畅率。
  • 肝素结合人工血管置入与血小板抗体形成尚无明确关联,但已有HIT病例报告。
  • 本例HIT经治疗成功并保留了透析通路,提示并非所有病例均需切除人工血管。

核心结论

  • 近期置入肝素结合ePTFE动静脉人工血管后发生HIT的罕见病例,经成功治疗可保留透析通路。

研究设计与样本

  • 个案报告,报告一例近期置入肝素结合ePTFE动静脉人工血管后发生HIT的病例。

主要发现

  • 该例HIT经成功治疗,透析通路得以保留,未行人工血管切除。

临床怎么用

  • 肝素结合人工血管置入后发生HIT时,可考虑在成功治疗HIT的同时保留透析通路,而非一律切除人工血管。

局限性

  • 仅为单例个案报告,结论的普遍适用性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Heparin-bonded expanded polytetrafluoroethylene (ePTFE) grafts are increasingly used for dialysis access in lieu of standard ePTFE grafts to improve patency. Despite no established association between heparin-bonded graft placement and formation of platelet antibodies, cases of heparin-induced thrombocytopenia (HIT) have been observed after use of lower extremity heparin-bonded grafts, often resulting in their explantation. We report a rare case of HIT in the setting of recent heparin-bonded ePTFE arteriovenous graft placement and successful treatment of the condition with preservation of dialysis access.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Levin SR, Farber A, Siracuse JJ, et al. Preservation of Heparin-Bonded Prosthetic Graft for Hemodialysis in the Setting of Early Heparin-Induced Thrombocytopenia. Ann Vasc Surg. 2020. PMID: 31904512. doi:10.1016/j.avsg.2019.12.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。